Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

MuscleCare: Natural as Strong as Drug in Topical Pain Relief


News provided by

MuscleCare

Feb 14, 2017, 08:30 ET

Share this article

Share toX

Share this article

Share toX

New University of Toronto Study Tackles Why Natural Products
May In Fact Be Superior to Over The Counter Pharma-Brands

TORONTO, Feb. 14, 2017 /PRNewswire/ - Data from a recent University of Toronto study answers the bated question: can an all-natural topical product be as effective as leading non-steroidal anti-inflammatory drug (NSAIDs)? The following double-blind study reveals that all-natural Professional Therapy MuscleCare is marginally more effective than Voltaren containing Diclofenac NSAID. [See Figure 1]

Figure 1 (CNW Group/MuscleCare)
Figure 1 (CNW Group/MuscleCare)
Figure 2 (CNW Group/MuscleCare)
Figure 2 (CNW Group/MuscleCare)
Figure 1 (CNW Group/MuscleCare) Figure 2 (CNW Group/MuscleCare)

Statistically, about one-third of the American population suffers from chronic pain. Not surprisingly, a rise in inflammatory response is a natural by-product of prolonged stationary postures; this is an inevitable consequence of our day-jobs as we progress towards an increasingly automated workforce. Research has demonstrated that extended periods of sitting have such a negative effect, that standing desks have started becoming a trend in many offices. It's become so detrimental that the phrase "Sitting is the New Smoking" has become popular among reputable media outlets such as Forbes, and The Huffington Post.

As a result, we often find ourselves reaching for pain-relief in many forms. Due to the laundry list of potential side-effects presented by popular pharmaceutical options, the importance for innovation in a safer alternative is more vital now than ever; this is especially critical given the addictive consequences many painkillers carry, in many ways similar to opioid use. "MuscleCare is as effective as Voltaren at relieving local tenderness in muscles, but it does not use a non-steroidal anti-inflammatory drug," says Dr. Howard Vernon, an international authority in musculoskeletal research.

MuscleCare represents a breakthrough as being the first all-natural clinically proven topical anti-inflammatory solution. The use of magnesium chloride reduces pain, inflammation, and muscle tension thanks to its unique delivery system. Ingredients permeate the superficial fascia, muscle, and joints to assist in creating a proven fast and effective pain reduction. Additionally, incorporating Hydresia SF-2 Oleosomes from safflower seeds greatly increases bioavailability, and offers the user a timed release pain-relief based on burst technology.

The science behind MuscleCare is novel: within 30–45 seconds, it breaks little cross bridges in the muscles to allow full relaxation, and facilitates ejection of toxic waste products responsible for pain and inflammation. The secret mechanism lies in MuscleCare's unique proprietary formula that quickly and effectively drives magnesium into the muscle tissue. This employs a method that works in a similar manner to a deep tissue massage, helping break up knots to alleviate the underlying cause of pain.

Our skin is made up of about 1600 pores per square inch, which makes it crucial that we avoid substances that are proven irritants and potentially carcinogenic agents. "90% of MuscleCare's competitors use parabens in their ingredients, which merely act as 'stabilizers' to ensure the product can sit on the shelf longer, but these suspected carcinogens have the opposite effect on a human being and do not assist in treating the symptom," states Dr. Chris Oswald, CEO and Founder of MuscleCare, and President of The Centre for Fitness, Health and Performance.  A cocktail of stabilizers used in topical applications (both in NSAIDs and non-NSAIDs) are bio-accumulative, inhibit absorption of the primary medical ingredient, and may produce undesirable hormonal changes. On the other hand, MuscleCare takes advantage of our skin's natural propensity for absorption by utilizing nourishing ingredients that remedies inflammation and pain.

According to a 2017 study out of the University of Toronto Training & Performance Lab, Dr. Jack Goodman states: "The MuscleCare formulation is healthier and equally effective to Voltaren." MuscleCare's success has been clinically proven time and time again. In another double-blind study, MuscleCare demonstrated statistical significance in outperforming leading national brands such as Biofreeze, and IcyHot in pain reduction. In fact, Biofreeze actually rendered subjects more sensitive to pain post-trial, as the use of menthol initially masks the pain sensation by shocking the nervous system, and can often lead to frequent reapplication to desensitize pain—when in fact the opposite is happening. An additional study out of Toronto's Motherisk: The Hospital for Sick Children, established MuscleCare as the only available topical pain-relief solution that is safe for pregnant and lactating women. [See Figure 2]

As the only leading natural Food & Drug Administration (FDA/NDC) and Health Canada registered OTC topical pain reliever with this much high-level scientific support, MuscleCare clearly demonstrates that focusing on natural ingredients can actually enhance the effectiveness of a product, making it both safer and superior to pharmaceutical alternatives.

Dr. Oswald has seen 20,000 patients in his 29 years of clinical experience treating muscle, joint, back pain. Recognizing the fundamental need for a safer alternative to NSAIDs, he worked on formulating MuscleCare. Typical pain relievers are laden with irritants such as parabens, dyes, waxes, and coloring agents to bind ingredients; unfortunately, this obstructs proper absorption. As a safer alternative, MuscleCare's bio-innovation has been shown to clinically, and scientifically reduce pain, inflammation, and spasm in all age groups.

About MuscleCare:
MuscleCare is an emerging brand in health and wellness solutions. Their leading products focus on topical pain-relief, and ergonomic equipment that help prevent, and reduce inflammation and stress. The company was pioneered by Dr. Chris Oswald, leading chiropractor and pain specialist, who has gained recognition as one of the nation's top 20 leaders by the Canadian Chiropractic Association under the age of 40. Dr. Oswald owns and operates one of Toronto's most prestigious chiropractic clinics with clients ranging from athletes, musicians, and business professionals. Their elite team includes professional kiteboarders Annabel van Westerop and Susi Mai; four-time world champion waterskier Whitney McClintock; NFL's Jamaal Charles; NBA's Glen "Big Baby" Davis; and NHL's Dave Bolland. MuscleCare is also a proud sponsor of the Canadian Memorial Chiropractic College, and the International Federation of Sports Chiropractic. MuscleCare gained recognition on QVC, as well as at Walgreens, Duane Reade, Shoppers Drug Mart, Rexall and Office Depot; now most of its business is online at http://musclecare.net as people in pain are increasingly turning to the Internet.

SOURCE MuscleCare

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.